ISDE presidential biography: J R Siewert

Autor: Arnulf H. Hoelscher

Publikováno v: Diseases of the Esophagus. 32

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59604e8d5ec96c302357cbb39789d42a
https://doi.org/10.1093/dote/doz027

Nachruf auf Prof. Dr. med. Volker Schumpelick

Autor: J. R. Siewert

Publikováno v: Der Chirurg. 93:256-256

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6f57cdf6d293a09e4d0c21c22e461390
https://doi.org/10.1007/s00104-022-01609-8

Clinics in gastroenterology, volume 8, No. 2. Post-surgical Syndromes. Edited A. L. Blum and J. R. Siewert. 235 × 155 mm. Pp. 547 + x. Illustrated. 1979. Eastbourne: Saunders. £8·25

Autor: A Cox

Publikováno v: British Journal of Surgery. 67:150-150

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a230d7c646ee87a3d255a5fdcb4d9698
https://doi.org/10.1002/bjs.1800670233

Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas

Autor: Florian Lordick, Thomas Bruckner, L Sicic, Thomas Schmidt, T Parakonthun, M.W. Büchler, K. Becker, Rupert Langer, Katja Ott, J-R Siewert, Wilko Weichert, Susanne Blank

Publikováno v: British Journal of Cancer
Schmidt, T; Sicic, L; Blank, S; Becker, K; Weichert, W; Bruckner, T; Parakonthun, T; Langer, Rupert; Büchler, M W; Siewert, J-R; Lordick, F; Ott, K (2014). Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas. British journal of cancer, 110(7), pp. 1712-1720. Nature Publishing Group 10.1038/bjc.2014.94

BACKGROUND Recently, histopathological tumour regression, prevalence of signet ring cells, and localisation were reported as prognostic factors in neoadjuvantly treated oesophagogastric (junctional and gastric) cancer. This exploratory retrospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b303e2dc738714e7cc1a17ffe6be6dfd
https://doi.org/10.1038/bjc.2014.94

A reliable risk score for stage IV esophagogastric cancer

Autor: Henning Schulze-Bergkamen, P. Compani, Martin Dobritz, M.W. Büchler, Lars Grenacher, Maria Burian, Dirk Jäger, Katja Ott, Leila Sisic, Susanne Blank, Hendrik Bläker, Florian Lordick, Rupert Langer, J. R. Siewert, Wilfried Roth, Anja Schaible, Annika Stange, Karen Becker

Publikováno v: European Journal of Surgical Oncology (EJSO). 39:823-830

Background The role of surgery for patients with metastatic esophagogastric adenocarcinoma (EGC) is not defined. The purpose of this study was to define selection criteria for patients who may benefit from resection following systemic chemotherapy. M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f31e7d950009113a544b48e2d0fe8a92
https://doi.org/10.1016/j.ejso.2013.01.005